Scheduled Maintenance Notice

Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.

Select Publications

Conference Papers

Burke DJ; Kiernan MC; Mogyoros I, 1998, 'Mechanisms of conduction slowing in carpal tunnel syndrome', in Muscle and Nerve, John Wiley & Sons Inc, Hoboken, NJ, USA, pp. S95 - S95, presented at IX International congress on neuromuscular diseases, Adelaide, Sth Aust, 30 August 1998 - 04 September 1998

Mogyoros I; Kiernan MC; Burke DJ, 1998, 'Pathophysiology of entrapment and compression neuropathies', in Muscle and Nerve, John Wiley & Sons Inc, Hoboken, NJ, USA, pp. S81 - S81, presented at IX International congress on neuromuscular diseases, Adelaide, Sth Aust, 30 August 1998 - 04 September 1998

Mogyoros I; Kiernan MC; Burke DJ; Bostock H, 1997, 'Axonal ion channel abnormality in amyotrophic lateral sclerosis', in Electromyography and Motor Control Electroencephalography and Clinical Neurophysiology, Elsevier Science Ireland Ltd, Limerick, Ireland, pp. 167 - 168, presented at 14th International Cong EEG and Clin Neurophysiol, Florence, Italy, 24 August 1997 - 30 August 1997

Kiernan MC; Mogyoros I; Hales JP; Gracies J; Burke DJ, 1997, 'Excitability changes and paraesthesiae following high-frequency stimulation of human cutaneous afferents', in Electromyography and Motor Control Electroencephalography and Clinical Neurophysiology, Elsevier Science Ireland Ltd, Limerick, Ireland, pp. 39 - 39, presented at 14th International Cong EEG and Clin Neurophysiol, Florence, Italy, 24 August 1997 - 30 August 1997

Mogyoros I; Kiernan MC; Burke DJ; Bostock H, 1997, 'Ion channel abnormality in motor axons in amyotrophic lateral sclerosis', in Journal of Clinical Neuroscience, Churchill Livingstone, Edinburgh, Midlothian, Scotland, pp. 402 - 403, presented at Australian Association of Neurologists Annual Scientific Meeting 1997, Sydney, 30 April 1997 - 02 May 1997

Kiernan MC; Hales JP; Gracies J; Mogyoros I; Burke DJ, 1997, 'Vagrant behaviour of hyperstimulated cutaneous afferent axons: a mechanism for paraesthesiae', in Journal of Clinical Neuroscience, Churchill Livingstone, Edinburgh, Midlothian, Scotland, pp. 397 - 397, presented at Australian Association of Neurologists Annual Scientific Meeting 1997, Sydney, 30 April 1997 - 02 May 1997

Mogyoros I; Kiernan MC; Burke DJ; Bostock H, 1996, 'Strength-duration properties of cutaneous afferents in motor neuron disease', in Electromyography and Motor Control Electroencephalography and Clinical Neurophysiology, Elsevier Science Ireland Ltd, Limerick, Ireland, pp. 62P - 62P, presented at 7th Biennial Clin Neurophysiol Workshop, Southport, Qld, 30 September 1996 - 02 October 1996

GERAGHTY JG; COVENEY EC; KIERNAN M; OHIGGINS NJ, 1992, 'A COMPARISON OF PLAIN RADIOLOGY AND FLOW VOLUME LOOP CURVES IN PATIENTS WITH GOITERS', in JOURNAL OF PHYSIOLOGY-LONDON, CAMBRIDGE UNIV PRESS, pp. P432 - P432, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1992HD60500423&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

GERAGHTY JG; COVENEY EC; KIERNAN M; OHIGGINS NJ, 1990, 'FLOW VOLUME LOOPS IN GOITERS', in BRITISH JOURNAL OF SURGERY, WILEY, pp. A1309 - A1309

Conference Presentations

Han SH; Lin CS-Y; Boland R; Kiernan MC, 2010, 'The effects of focal nerve compression in carpal tunnel syndrome', presented at 11th Triennial Congress of the International Federation of Societies for Surgery of the Hand, Seoul, Korea, 31 October 2010 - 04 November 2010

Kiernan MC, 2010, 'Hyperexcitability, persistent Na+ conductances and ndurodegeneration in motor neurone disease', presented at Australian Neurosciences Society Annual Scientific Meeting 2010, Sydney, 31 January 2010 - 03 February 2010

Cheah BC; Boland R; Jeffrey S; Mckenzie DK; Kiernan MC, 2008, 'Inspirational (Inspiratory Training in Amyotrophic Lateral Sclerosis)', presented at Australian and New Zealand Association of Neurologists Annual Scientific Meeting 2008, Brisbane, 19 May 2008 - 23 May 2008

Conference Abstracts

Gray E; Mcguiness O; Menadue C; Piper A; Wong K; Kiernan M; Yee B, 2026, 'DIAPHRAGM ULTRASOUND AS A PROGNOSTIC TOOL IN MOTOR NEURON DISEASE: EVIDENCE BEYOND CONVENTIONAL LUNG FUNCTION', in INTERNAL MEDICINE JOURNAL, WILEY, Vol. 56, pp. 63 - 64

Li T; Timmins HC; Mahfouz FM; Mizrahi D; Horvath L; Harrison ML; Grimison PS; Friedlander M; Marx GM; Boyle FM; Wyld D; Henderson R; King T; Baron-Hay SE; Kiernan MC; Rutherford C; Goldstein D; Park SB, 2024, 'Identifying optimized assessment of nerve damage during chemotherapy', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, Vol. 42, presented at Special Clinical Science Symposia, ELECTR NETWORK, 29 May 2024 - 29 May 2024

Park S; Morrow A; Grimison P; Boyle F; King T; Koczwara B; Harris C; Robinson L; Mendoza-Jones P; Mizrahi D; Pitiyarachchi O; Huynh W; Kiernan M; Grogan P; Goldstein D; Taylor N, 2024, 'Using Health Implementation Strategies to Improve Patient Outcomes via a Clinical Pathway for Chemotherapy-Induced Peripheral Neuropathy Assessment and Management', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 20, pp. 55 - 56

Mizrahi D; Goldstein D; Kiernan MC; Robinson L; Pitiyarachchi O; McCullough S; Mendoza-Jones P; Grimison P; Boyle F; Park SB, 2022, 'Development and consensus of 'CIPN-path': A clinical pathway for the assessment and management of chemotherapy-induced peripheral neuropathy', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 190 - 190

Li T; Timmins HC; Trinh T; Mizrahi D; Horvath L; Grimison P; Harrison M; Rutherford C; King M; Kiernan MC; Goldstein D; Park SB, 2021, 'Assessing chemotherapy-induced peripheral neuropathy - A psychometric analysis of current approaches', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 17, pp. 31 - 32, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693805000054&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kang A; Arnold R; Gallagher M; Snelling P; Green J; Fernando M; Kiernan M; Hand S; Grimley K; Burman J; Heath A; Rogers K; Bhattacharya A; Smyth B; Bradbury T; Hawley C; Perkovic V; Krishnan AV; Jardine M, 2020, 'THE FILTRATION IN THE NEUROPATHY OF END-STAGE KIDNEY DISEASE (FINESSE) RANDOMISED CONTROLLED TRIAL', in NEPHROLOGY, WILEY, Vol. 25, pp. 11 - 11

Timmins H; Li T; Kiernan M; Harrison M; Trinh T; Battaglini E; Goldstein D; Park S, 2020, 'Dose modification: Does it affect follow-up outcomes in taxane-induced neuropathy?', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY, ELECTR NETWORK, Vol. 25, pp. 480 - 481, presented at Virtual Conference of Peripheral-Nerve-Society, ELECTR NETWORK

Li T; Timmins H; McCrary J; Trinh T; Friedlander M; Horvath L; Kiernan M; Goldstein D; Park S, 2020, 'Patient reported outcome scores used in chemotherapy-induced peripheral neuropathy: Defining minimal important differences', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY, ELECTR NETWORK, Vol. 25, pp. 481 - 481, presented at Virtual Conference of Peripheral-Nerve-Society, ELECTR NETWORK

Farrar MA; Tomlinson SE; Howells J; Lin CS-Y; Carey K; Park SB; Hollingsworth G; Lawson JA; Kiernan MC; Berkovic SF; Burke D; Scheffer IE, 2019, '009 Axonal excitability properties in dravet’s syndrome reflect effect of loss of sodium channels', in Journal of Neurology Neurosurgery & Psychiatry, BMJ, Vol. 90, pp. a4.1 - a4a4, http://dx.doi.org/10.1136/jnnp-2019-anzan.9

Garg N; Park S; Howells J; Noto Y-I; Vucic S; Yiannikas C; Tomlinson S; Huynh W; Simon N; Mathey E; Spies J; Pollard J; Krishnan A; Kiernan M, 2018, 'Anti-MAG neuropathy: Role of IgM antibodies, the paranodal junction and juxtaparanodal potassium channels', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY, MD, Baltimore, Vol. 23, pp. 275 - 275, presented at Annual Meeting of the Peripheral-Nerve-Society, MD, Baltimore, 21 July 2018 - 25 July 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000452787700066&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Timmins HC; Li T; Kiernan MC; Horvath LG; Harrison M; Grimison P; Cox KM; Boyle FM; Goldstein D; Park SB, 2017, 'NEUROPHYSIOLOGICAL MEASURES CORRELATE WITH PATIENT REPORTED SYMPTOMS OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY, SPAIN, Sitges, Vol. 22, pp. 395 - 396, presented at Peripheral-Nerve-Society Meeting, SPAIN, Sitges, 08 July 2017 - 12 July 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000409243500424&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Menon P; Geevasinga N; Van den Bos M; Yiannikas C; Kiernan MC; Vucic S, 2017, 'CORTICAL HYPEREXCITABILITY MAY CONTRIBUTE TO DISEASE SPREAD IN ALS', in JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, BMJ PUBLISHING GROUP, AUSTRALIA, Gold Coast, Vol. 88, presented at Annual Scientific Meeting of the Australian-and-New-Zealand-Association-of-Neurologists (ANZAN), AUSTRALIA, Gold Coast, 09 May 2017 - 12 May 2017, http://dx.doi.org/10.1136/jnnp-2017-316074.20

Geevasinga N; korgaonkar M; Menon P; Van Den Bos M; Gomes L; Forster S; Kiernan M; Vucic S, 2017, 'Functional and structural connectivity in als: insights from mri connectome analyses and tms', in Journal of Neurology Neurosurgery & Psychiatry, BMJ, Vol. 88, pp. e1, http://dx.doi.org/10.1136/jnnp-2017-316074.21

Halliday G; Tan R; Fatima M; Hodges J; Kiernan M; Kril J, 2016, 'Evidence from human studies for spreading/staging of TDP-43 pathology in FTLD and ALS', in JOURNAL OF NEUROCHEMISTRY, WILEY-BLACKWELL, GERMANY, Munich, Vol. 138, pp. 235 - 235, presented at 10th International Conference on Frontotemporal Dementias, GERMANY, Munich, 31 August 2016 - 02 September 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000382568400038&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tan R; Kiernan M; Kril J; Hasegawa M; Masada-Suzukake M; Dobson-Stone C; Kwok J; Hornberger M; Hodges J; Halliday G, 2016, 'TDP-43 in the hypoglossal nucleus identifies amyotrophic lateral sclerosis in behavioral variant frontotemporal dementia', in JOURNAL OF NEUROCHEMISTRY, WILEY-BLACKWELL, GERMANY, Munich, Vol. 138, pp. 367 - 367, presented at 10th International Conference on Frontotemporal Dementias, GERMANY, Munich, 31 August 2016 - 02 September 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000382568400375&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Theses / Dissertations

Kiernan MC, 1997, Activity-dependent changes in axonal excitability

Preprints

Zussa ZN; Smith AN; van Vugt JJFA; O’Shaughnessy DS; Grima N; Chan Moi Fat S; Blair IP; Rowe DB; Pamphlett R; Nicholson GA; Kiernan MCK; van Rheenen W; Veldink J; Williams KL; Henden L, 2026, Characterising the motif composition and allele length distribution of ZFHX3 GGC repeat expansions in amyotrophic lateral sclerosis, http://dx.doi.org/10.64898/2026.03.09.26347973

Wang X; Barnett M; Boonstra F; Barnett Y; Cabezas M; D'Souza A; Kiernan MC; Kyle K; Law M; Masters L; Tang Z; Tisch S; Tu S; Van Der Walt A; Wang D; Calamante F; Cai W; Wang C, 2025, From Promise to Practical Reality: Transforming Diffusion MRI Analysis with Fast Deep Learning Enhancement, http://dx.doi.org/10.48550/arxiv.2508.10950

Willemse SW; Roes KCB; Damme PV; Hardiman O; Ingre C; Povedano M; Wray N; Gijzen M; de Pagter M; Demaegd K; Janse AFC; Vink R; Sleutjes BTHM; Chiò A; Corcia P; Reviers E; Al-Chalabi A; Kiernan M; Berg LVD; Es MV; Eijk RPAV, 2022, Lithium carbonate in Amyotrophic Lateral Sclerosis patients homozygous for the C-allele at SNP rs12608932 in UNC13A; protocol for a confirmatory, randomized, group-sequential, event-driven, double-blind, placebo-controlled trial., http://dx.doi.org/10.21203/rs.3.rs-2125381/v1

Gold J; Rowe DB; Kiernan MC; Vucic S; Mathers S; van Eijk RP; Nath A; Montojo MG; Norato G; Santamaria UA; Rogers M-L; Malaspina A; Lombardi V; Mehta PR; Westeneng H-J; van den Berg LH; Al-Chalabi A, 2019, Safety and Tolerability of Triumeq in Amyotrophic Lateral Sclerosis: The Lighthouse Trial, http://dx.doi.org/10.2139/ssrn.3347916

Project MinE ALS Sequencing Consortium , 2018, The Project MinE databrowser: bringing large-scale whole-genome sequencing in ALS to researchers and the public, http://dx.doi.org/10.1101/377911

Ribeiro FL; Zhu X; Ye X; Tu S; Ngo ST; Henderson RD; Steyn FJ; Kiernan MC; Barth M; Bollmann S; Shaw TB, An Annotated Multi-Site and Multi-Contrast Magnetic Resonance Imaging Dataset for the study of the Human Tongue Musculature, http://dx.doi.org/10.1101/2024.12.09.24318591

van Rheenen W; van der Spek RAA; Bakker MK; van Vugt JJFA; Hop PJ; Zwamborn RAJ; de Klein N; Westra H-J; Bakker OB; Deelen P; Shireby G; Hannon E; Moisse M; Baird D; Restuadi R; Dolzhenko E; Dekker AM; Gawor K; Westeneng H-J; Tazelaar GHP; van Eijk KR; Kooyman M; Byrne RP; Doherty M; Heverin M; Al Khleifat A; Iacoangeli A; Shatunov A; Ticozzi N; Cooper-Knock J; Smith BN; Gromicho M; Chandran S; Pal S; Morrison KE; Shaw PJ; Hardy J; Orrell RW; Sendtner M; Meyer T; Başak N; van der Kooi AJ; Ratti A; Fogh I; Gellera C; Pinter GL; Corti S; Cereda C; Sproviero D; D’Alfonso S; Sorarù G; Siciliano G; Filosto M; Padovani A; Chiò A; Calvo A; Moglia C; Brunetti M; Canosa A; Grassano M; Beghi E; Pupillo E; Logroscino G; Nefussy B; Osmanovic A; Nordin A; Lerner Y; Zabari M; Gotkine M; Baloh RH; Bell S; Vourc’h P; Corcia P; Couratier P; Millecamps S; Meininger V; Salachas F; Pardina JSM; Assialioui A; Rojas-García R; Dion P; Ross JP; Ludolph AC; Weishaupt JH; Brenner D; Freischmidt A; Bensimon G; Brice A; Dürr A; Payan CAM; Saker-Delye S; Wood N; Topp S; Rademakers R; Tittmann L; Lieb W; Franke A; Ripke S; Braun A; Kraft J; Whiteman DC; Olsen CM; Uitterlinden AG; Hofman A; Rietschel M; Cichon S; Nöthen MM; Amouyel P; Consortium S; Consortium P; Consortium S; Consortium S; Traynor B; Singleton AB; Neto MM; Cauchi RJ; Ophoff RA; Wiedau-Pazos M; Lomen-Hoerth C; van Deerlin VM; Grosskreutz J; Rödiger A; Gaur N; Jörk A; Barthel T; Theele E; Ilse B; Stubendorff B; Witte OW; Steinbach R; Hübner CA; Graff C; Brylev L; Fominykh V; Demeshonok V; Ataulina A; Rogelj B; Koritnik B; Zidar J; Ravnik-Glavač M; Glavač D; Stević Z; Drory V; Povedano M; Blair IP; Kiernan MC; Benyamin B; Henderson RD; Furlong S; Mathers S; McCombe PA; Needham M; Ngo ST; Nicholson GA; Pamphlett R; Rowe DB; Steyn FJ; Williams KL; Mather K; Sachdev PS; Henders AK; Wallace L; de Carvalho M; Pinto S; Petri S; Osmanovic A; Weber M; Rouleau GA; Silani V; Curtis C; Breen G; Glass J; Brown RH; Landers JE; Shaw CE; Andersen PM; Groen EJN; van Es MA; Pasterkamp RJ; Fan D; Garton FC; McRae AF; Smith GD; Gaunt TR; Eberle MA; Mill J; McLaughlin RL; Hardiman O; Kenna KP; Wray NR; Tsai E; Runz H; Franke L; Al-Chalabi A; Van Damme P; van den Berg LH; Veldink JH, Common and rare variant association analyses in Amyotrophic Lateral Sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology, http://dx.doi.org/10.1101/2021.03.12.21253159

Rheenen WV; Spek RVD; Bakker M; Berg LVD; Veldink J; Vugt JV; Hop P; Zwamborn R; de Klein N; Westra H-J; Bakker O; Deelen P; Shireby G; Hannon E; Moisse M; Baird D; Restuadi R; Dolzhenko E; Dekker A; Gawor K; Westeneng H-J; Tazelaar G; Eijk KV; Kooyman M; Byrne R; Doherty M; Heverin M; Khleifat AA; Iacoangeli A; Shatunov A; Ticozzi N; Cooper-Knock J; Smith B; Gromicho M; Chandran S; Pal S; Morrison K; Shaw P; Hardy J; Orrell R; Sendtner M; Meyer T; Basak N; Kooi AVD; Ratti A; Fogh I; Gellera C; Pinter GL; Corti S; Cereda C; Sproviero D; D'Alfonso S; Soraru G; Siciliano G; Filosto M; Padovani A; Chio A; Calvo A; Moglia C; Brunetti M; Canosa A; Grassano M; Beghi E; Pupillo E; Logroscino G; Nefussy B; Osmanovic A; Nordin A; Lerner Y; Zabari M; Gotkine M; Baloh R; Bell S; Vourc'h P; Corcia P; Couratier P; Millecamps S; Meininger V; Salachas F; Pardina JM; Assialioui A; Rojas-García R; Dion P; Ross J; Ludolph A; Weishaupt J; Brenner D; Freischmidt A; Bensimon G; Brice A; Durr A; Payan C; Saker-Delye S; Wood N; Topp S; Rademakers R; Tittmann L; Lieb W; Franke A; Ripke S; Braun A; Kraft J; Whiteman D; Olsen C; Uitterlinden A; Hofman A; Rietschel M; Cichon S; Nöthen M; Amouyel P; Traynor B; Singleton A; Neto MM; Cauchi R; Ophoff R; Wiedau-Pazos M; Lomen-Hoerth C; Deerlin VV; Grosskreutz J; Rödiger A; Jörk A; Barthel T; Theele E; Ilse B; Stubendorff B; Witte O; Steinbach R; Hübner C; Graff C; Brylev L; Fominykh V; Demeshonok V; Ataulina A; Rogelj B; Koritnik B; Zidar J; Ravnik-Glavač M; Glavač D; Stević Z; Drory V; Povedano M; Blair I; Kiernan M; Benyamin B; Henderson R; Furlong S; Mathers S; McCombe P; Needham M; Ngo S; Nicholson G; Pamphlett R; Rowe D; Steyn F; Williams K; Mather K; Sachdev P; Henders A; Wallace L; de Carvalho M; Pinto S; Petri S; Weber M; Rouleau G; Silani V; Curtis C; Breen G; Glass J; Brown R; Landers J; Shaw C; Andersen P; Groen E; Es MV; Pasterkamp J; Fan D; Garton F; McRae A; Smith GD; Gaunt T; Eberle M; Mill J; McLaughlin R; Hardiman O; Kenna K; Wray N; Tsai E; Runz H; Franke L; Al-Chalabi A; Damme PV; Gaur N, Common and rare variant association analyses in Amyotrophic Lateral Sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology, http://dx.doi.org/10.21203/rs.3.rs-322430/v1

Haidar M; Viden A; Cuic B; Wang T; Rosier M; Tomas D; Mills SA; Govier-Cole A; Djouma E; Luikinga S; Rytova V; Barton SK; Gonsalvez DG; Palmer LM; McLean C; Kiernan MC; Vucic S; Turner BJ, Cortical hyperexcitability drives dying forward ALS symptoms and pathology in mice, http://dx.doi.org/10.1101/2021.08.13.456320

Byrne RP; van Rheenen W; Consortium PMAG; van den Berg LH; Veldink JH; McLaughlin RL, Dutch population structure across space, time and GWAS design, http://dx.doi.org/10.1101/2020.01.01.892513

Hop PJ; Zwamborn RAJ; Hannon E; Shireby GL; Nabais MF; Walker EM; van Rheenen W; van Vugt JJFA; Dekker AM; Westeneng H-J; Tazelaar GHP; van Eijk KR; Moisse M; Baird D; Al Khleifat A; Iacoangeli A; Ticozzi N; Ratti A; Cooper-Knock J; Morrison KE; Shaw PJ; Basak AN; Chiò A; Calvo A; Moglia C; Canosa A; Brunetti M; Grassano M; Gotkine M; Lerner Y; Zabari M; Vourc’h P; Corcia P; Couratier P; Pardina JSM; Salas T; Dion P; Ross JP; Henderson RD; Mathers S; McCombe PA; Needham M; Nicholson G; Rowe DB; Pamphlett R; Mather KA; Sachdev PS; Furlong S; Garton FC; Henders AK; Lin T; Ngo ST; Steyn FJ; Wallace L; Williams KL; Consortium B; Consortium BM; Neto MM; Cauchi RJ; Blair IP; Kiernan MC; Drory V; Povedano M; de Carvalho M; Pinto S; Weber M; Rouleau G; Silani V; Landers JE; Shaw CE; Andersen PM; McRae AF; van Es MA; Pasterkamp RJ; Wray NR; McLaughlin RL; Hardiman O; Kenna KP; Tsai E; Runz H; Al-Chalabi A; van den Berg LH; Van Damme P; Mill J; Veldink JH, Genome-wide study of DNA methylation in Amyotrophic Lateral Sclerosis identifies differentially methylated loci and implicates metabolic, inflammatory and cholesterol pathways, http://dx.doi.org/10.1101/2021.03.12.21253115

Eftekhari Z; Tu S; Ballard T; Eckstein K; Strasser B; Niess F; Hingerl L; Bogner W; Kiernan MC; Henderson RD; Barth M; Shaw TB, Glutamine and NAA dissociate in ALS across somatotopically defined motor regions using 7T MRSI, http://dx.doi.org/10.64898/2026.07.09.26357702

Henden L; Twine NA; Szul P; McCann EP; Nicholson GA; Rowe DB; Kiernan MC; Bauer DC; Blair IP; Williams KL, IBD analysis of Australian amyotrophic lateral sclerosis SOD1-mutation carriers identifies five founder events and links sporadic cases to existing ALS families, http://dx.doi.org/10.1101/685925

Krishnan D; Talbot D-L; Ashhurst JF; Park SB; Vucic S; Timmins HC; Kiernan MC, Longitudinal Assessment of Cortical Motor Function in Amyotrophic Lateral Sclerosis, http://dx.doi.org/10.21203/rs.3.rs-5816527/v1

Li T; Timmins HC; Horvath LG; Harrison M; Grimison P; Friedlander M; Marx G; Boyle F; Wyld D; Henderson R; King T; Baron-Hay S; Kiernan MC; Barnes EH; Goldstein D; Park SB, Peripheral Neuropathy in Cancer Patients- Multifactorial Contributors to Dose Limiting and Chronic Toxicity, http://dx.doi.org/10.1101/2024.07.24.24310956

Shaw TB; Ribeiro FL; Zhu X; Aiken P; Bollmann S; Bollmann S; Chang J; Chidley K; Dempsey-Jones H; Eftekhari Z; Gillespie J; Henderson RD; Kiernan MC; Ktena I; McCombe PA; Ngo ST; Taubert ST; Whelan B-M; Ye X; Steyn FJ; Tu S; Barth M, Segmentation of the Human Tongue Musculature Using MRI: Field Guide and Validation in Motor Neuron Disease, http://dx.doi.org/10.1101/2024.12.12.24318964

Eisen A; Kiernan M, The Neonatal Microbiome: Implications for Amyotrophic Lateral Sclerosis, http://dx.doi.org/10.20944/preprints202501.1027.v1

Other

Geevasinga N; Menon P; Scherman DB; Simon N; Yiannikas C; Henderson RD; Kiernan MC; Vucic S, 2017, Author response: Diagnostic criteria in amyotrophic lateral sclerosis: A multicenter prospective study, http://dx.doi.org/10.1212/WNL.0000000000003628

ANSTETT R; BROWN R; STEPHENS C; SULLIVAN N; KIERNAN M; ROJEC M; SHREIBMAN W; NANNA R, 1987, THE GAY LESBIAN PATIENT AND THE FAMILY PHYSICIAN, APPLETON & LANGE


Back to profile page